| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.5 | 0.07 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.28 | 0.08 |